ung disease prevention encompasses strategies aimed at reducing the risk of both acute and chronic respiratory conditions, preserving lung function, and enhancing overall respiratory health. Environmental exposures, smoking, occupational hazards, air pollution, and infections are major contributors to lung morbidity. Preventive measures target these risk factors through lifestyle modification, early detection, immunization, and workplace safety interventions. Educating individuals about the harmful effects of tobacco, secondhand smoke, and environmental pollutants is critical to reducing the incidence of conditions such as chronic obstructive pulmonary disease, lung cancer, and asthma. Nutritional optimization, regular physical activity, and respiratory hygiene practices further support lung resilience and immunity.
Routine screening programs, including spirometry for at-risk populations, facilitate early detection of obstructive or restrictive lung conditions. Vaccinations against influenza, pneumococcus, and other respiratory pathogens minimize infection-related exacerbations. Occupational health regulations, clean indoor air policies, and reduction of environmental pollutants protect communities and vulnerable populations. Targeted interventions for high-risk groups, including children, the elderly, and individuals with pre-existing respiratory conditions, ensure tailored preventive strategies. Multidisciplinary collaboration among public health officials, clinicians, and community organizations is essential to implement and monitor these initiatives. By integrating individual, community, and policy-level measures, lung disease prevention efforts reduce disease burden, improve quality of life, and support long-term respiratory wellness across diverse populations.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation